Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Total 13F shares
-
36,309,263
-
Share change
-
+3,055,371
-
Total reported value
-
$1,175,380,829
-
Put/Call ratio
-
85%
-
Price per share
-
$32.40
-
Number of holders
-
141
-
Value change
-
+$118,344,229
-
Number of buys
-
78
-
Number of sells
-
84
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2015
As of 31 Dec 2015,
PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,309,263 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, FMR LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, WADDELL & REED FINANCIAL INC, Sectoral Asset Management Inc, STATE STREET CORP, WELLS FARGO & COMPANY/MN, PUTNAM INVESTMENTS LLC, and BB BIOTECH AG.
This page lists
141
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.